A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients

NCT04152148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

BIOLOGICAL: 500mg BAT4306F
BIOLOGICAL: 750mg BAT4306F
BIOLOGICAL: 900mg BAT4306F
BIOLOGICAL: 1000mg BAT4306F

Sponsor

Bio-Thera Solutions